Gritstone bio to Participate in Upcoming Investor Conference
17 Januar 2024 - 1:00PM
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology
company working to develop the world’s most potent vaccines, today
announced that management will be participating in the following
investor conference:
B. Riley
Securities' 4th
Annual Oncology Conference (Fireside
Chat)Date and Time: Thursday, January 18,
2024 at 1:30pm ETPresenter: Andrew Allen, M.D.,
Ph.D., Co-founder, President, and Chief Executive Officer
A live webcast of the fireside chat will be available via
https://ir.gritstonebio.com/investors/events. An archived replay
will be accessible for 30 days following each event.
About Gritstone bioGritstone bio, Inc. (Nasdaq:
GRTS) is a clinical-stage biotechnology company that aims to
develop the world’s most potent vaccines. We leverage our
innovative vectors and payloads to train multiple arms of the
immune system to attack critical disease targets. Independently and
with our collaborators, we are advancing a portfolio of product
candidates to treat and prevent viral diseases and solid tumors in
pursuit of improving patient outcomes and eliminating disease.
www.gritstonebio.com
Gritstone ContactsInvestors:George E.
MacDougallGritstone bio, Inc.ir@gritstone.com
Media:Dan Budwick1AB(973) 271-6085dan@1abmedia.com
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024